Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
Clinical trial NCT03937219 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03937219
- Sponsor
- Exelixis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2022-01-31
- Enrollment
- 855
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.